Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free ETHZ Stock Alerts

Flag Ship Acquisition (ETHZ) Competitors

Flag Ship Acquisition logo
$5.49 -0.36 (-6.15%)
As of 05/4/2026
Compare

ETHZ vs. FBRX, AGMB, IVVD, NAGE, and PBYI

Should you be buying Flag Ship Acquisition stock or one of its competitors? The main competitors of Flag Ship Acquisition include Forte Biosciences (FBRX), AgomAb Therapeutics (AGMB), Invivyd (IVVD), Niagen Bioscience (NAGE), and Puma Biotechnology (PBYI). These companies are all part of the "pharmaceutical products" industry.

How does Flag Ship Acquisition compare to Forte Biosciences?

Flag Ship Acquisition (NASDAQ:ETHZ) and Forte Biosciences (NASDAQ:FBRX) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Flag Ship Acquisition has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 3.01, indicating that its share price is 201% more volatile than the S&P 500.

Forte Biosciences has a consensus target price of $67.00, indicating a potential upside of 145.51%. Given Forte Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Forte Biosciences is more favorable than Flag Ship Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flag Ship Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Forte Biosciences
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Flag Ship Acquisition has higher revenue and earnings than Forte Biosciences. Forte Biosciences is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flag Ship Acquisition$4.11M25.39-$6.17M-$159.65N/A
Forte BiosciencesN/AN/A-$69.38M-$4.77N/A

Forte Biosciences' return on equity of -98.36% beat Flag Ship Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Flag Ship AcquisitionN/A -185.71% -83.12%
Forte Biosciences N/A -98.36%-82.81%

In the previous week, Forte Biosciences had 3 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 3 mentions for Forte Biosciences and 0 mentions for Flag Ship Acquisition. Forte Biosciences' average media sentiment score of 1.11 beat Flag Ship Acquisition's score of 0.00 indicating that Forte Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Flag Ship Acquisition Neutral
Forte Biosciences Positive

4.1% of Flag Ship Acquisition shares are owned by institutional investors. Comparatively, 77.6% of Forte Biosciences shares are owned by institutional investors. 15.1% of Flag Ship Acquisition shares are owned by company insiders. Comparatively, 5.9% of Forte Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Forte Biosciences beats Flag Ship Acquisition on 10 of the 14 factors compared between the two stocks.

How does Flag Ship Acquisition compare to AgomAb Therapeutics?

Flag Ship Acquisition (NASDAQ:ETHZ) and AgomAb Therapeutics (NASDAQ:AGMB) are both small-cap manufacturing companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

4.1% of Flag Ship Acquisition shares are owned by institutional investors. 15.1% of Flag Ship Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

AgomAb Therapeutics has a consensus target price of $32.00, indicating a potential upside of 156.00%. Given AgomAb Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe AgomAb Therapeutics is more favorable than Flag Ship Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flag Ship Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
AgomAb Therapeutics
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

AgomAb Therapeutics' return on equity of 0.00% beat Flag Ship Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Flag Ship AcquisitionN/A -185.71% -83.12%
AgomAb Therapeutics N/A N/A N/A

In the previous week, AgomAb Therapeutics had 1 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 1 mentions for AgomAb Therapeutics and 0 mentions for Flag Ship Acquisition. Flag Ship Acquisition's average media sentiment score of 0.00 equaled AgomAb Therapeutics'average media sentiment score.

Company Overall Sentiment
Flag Ship Acquisition Neutral
AgomAb Therapeutics Neutral

AgomAb Therapeutics has lower revenue, but higher earnings than Flag Ship Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flag Ship Acquisition$4.11M25.39-$6.17M-$159.65N/A
AgomAb TherapeuticsN/AN/AN/AN/AN/A

Summary

AgomAb Therapeutics beats Flag Ship Acquisition on 6 of the 9 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Invivyd?

Invivyd (NASDAQ:IVVD) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

70.4% of Invivyd shares are held by institutional investors. Comparatively, 4.1% of Flag Ship Acquisition shares are held by institutional investors. 12.3% of Invivyd shares are held by insiders. Comparatively, 15.1% of Flag Ship Acquisition shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Invivyd has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Flag Ship Acquisition has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.

Invivyd presently has a consensus target price of $8.00, indicating a potential upside of 475.54%. Given Invivyd's stronger consensus rating and higher probable upside, equities research analysts clearly believe Invivyd is more favorable than Flag Ship Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Invivyd
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Flag Ship Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Flag Ship Acquisition has a net margin of 0.00% compared to Invivyd's net margin of -98.25%. Invivyd's return on equity of -48.65% beat Flag Ship Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Invivyd-98.25% -48.65% -34.48%
Flag Ship Acquisition N/A -185.71%-83.12%

In the previous week, Invivyd had 3 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 3 mentions for Invivyd and 0 mentions for Flag Ship Acquisition. Invivyd's average media sentiment score of 0.27 beat Flag Ship Acquisition's score of 0.00 indicating that Invivyd is being referred to more favorably in the media.

Company Overall Sentiment
Invivyd Neutral
Flag Ship Acquisition Neutral

Flag Ship Acquisition has lower revenue, but higher earnings than Invivyd. Invivyd is trading at a lower price-to-earnings ratio than Flag Ship Acquisition, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invivyd$53.43M7.36-$52.49M-$0.32N/A
Flag Ship Acquisition$4.11M25.39-$6.17M-$159.65N/A

Summary

Invivyd beats Flag Ship Acquisition on 10 of the 16 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Niagen Bioscience?

Niagen Bioscience (NASDAQ:NAGE) and Flag Ship Acquisition (NASDAQ:ETHZ) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

Niagen Bioscience has a beta of 2.17, indicating that its share price is 117% more volatile than the S&P 500. Comparatively, Flag Ship Acquisition has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500.

Niagen Bioscience has higher revenue and earnings than Flag Ship Acquisition. Flag Ship Acquisition is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Niagen Bioscience$129.42M2.98$17.38M$0.2024.10
Flag Ship Acquisition$4.11M25.39-$6.17M-$159.65N/A

In the previous week, Niagen Bioscience had 1 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 1 mentions for Niagen Bioscience and 0 mentions for Flag Ship Acquisition. Niagen Bioscience's average media sentiment score of 0.00 equaled Flag Ship Acquisition'saverage media sentiment score.

Company Overall Sentiment
Niagen Bioscience Neutral
Flag Ship Acquisition Neutral

Niagen Bioscience has a net margin of 13.43% compared to Flag Ship Acquisition's net margin of 0.00%. Niagen Bioscience's return on equity of 21.10% beat Flag Ship Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Niagen Bioscience13.43% 21.10% 14.92%
Flag Ship Acquisition N/A -185.71%-83.12%

15.4% of Niagen Bioscience shares are owned by institutional investors. Comparatively, 4.1% of Flag Ship Acquisition shares are owned by institutional investors. 9.4% of Niagen Bioscience shares are owned by company insiders. Comparatively, 15.1% of Flag Ship Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Niagen Bioscience presently has a consensus target price of $15.00, indicating a potential upside of 211.20%. Given Niagen Bioscience's stronger consensus rating and higher possible upside, research analysts clearly believe Niagen Bioscience is more favorable than Flag Ship Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Niagen Bioscience
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Flag Ship Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Niagen Bioscience beats Flag Ship Acquisition on 13 of the 15 factors compared between the two stocks.

How does Flag Ship Acquisition compare to Puma Biotechnology?

Flag Ship Acquisition (NASDAQ:ETHZ) and Puma Biotechnology (NASDAQ:PBYI) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

Puma Biotechnology has higher revenue and earnings than Flag Ship Acquisition. Flag Ship Acquisition is trading at a lower price-to-earnings ratio than Puma Biotechnology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flag Ship Acquisition$4.11M25.39-$6.17M-$159.65N/A
Puma Biotechnology$228.37M1.64$31.11M$0.6112.05

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flag Ship Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Puma Biotechnology
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Flag Ship Acquisition has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Puma Biotechnology has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.

4.1% of Flag Ship Acquisition shares are held by institutional investors. Comparatively, 61.3% of Puma Biotechnology shares are held by institutional investors. 15.1% of Flag Ship Acquisition shares are held by insiders. Comparatively, 23.3% of Puma Biotechnology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Puma Biotechnology had 2 more articles in the media than Flag Ship Acquisition. MarketBeat recorded 2 mentions for Puma Biotechnology and 0 mentions for Flag Ship Acquisition. Flag Ship Acquisition's average media sentiment score of 0.00 equaled Puma Biotechnology'saverage media sentiment score.

Company Overall Sentiment
Flag Ship Acquisition Neutral
Puma Biotechnology Neutral

Puma Biotechnology has a net margin of 13.62% compared to Flag Ship Acquisition's net margin of 0.00%. Puma Biotechnology's return on equity of 27.80% beat Flag Ship Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Flag Ship AcquisitionN/A -185.71% -83.12%
Puma Biotechnology 13.62%27.80%15.35%

Summary

Puma Biotechnology beats Flag Ship Acquisition on 12 of the 13 factors compared between the two stocks.

Get Flag Ship Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETHZ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ETHZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ETHZ vs. The Competition

Export
MetricFlag Ship Acquisition IndustryManufacturing SectorNASDAQ Exchange
Market Cap$104.38M$2.90B$4.21B$11.87B
Dividend YieldN/A15.26%5.61%5.21%
P/E Ratio-0.0313.1623.4028.47
Price / Sales25.391,690.53186.8560.94
Price / CashN/A25.7552.8236.52
Price / Book0.193.5538.316.67
Net Income-$6.17M-$42.77M$114.66M$332.53M
7 Day Performance1.29%1.11%1.23%2.01%
1 Month Performance99.64%5.45%5.54%9.20%
1 Year PerformanceN/A19.86%18.68%39.59%

Flag Ship Acquisition Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ETHZ
Flag Ship Acquisition
N/A$5.49
-6.2%		N/AN/A$104.38M$4.11MN/A7
FBRX
Forte Biosciences
3.2025 of 5 stars		$28.03
+6.2%		$67.00
+139.0%		N/A$389.23MN/AN/A5
AGMB
AgomAb Therapeutics
N/A$10.74
+0.9%		$32.00
+198.0%		N/A$389.19MN/AN/A62
IVVD
Invivyd
2.3222 of 5 stars		$1.36
-1.4%		$8.00
+488.2%		N/A$384.61M$53.43MN/A100
NAGE
Niagen Bioscience
3.3065 of 5 stars		$4.76
-1.7%		$16.00
+236.1%		N/A$381.18M$129.42M23.80120

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ETHZ) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel